Everence Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,984
| Closed | -$67 | – | 780 |
|
|
2022
Q4 | $67 | Sell |
1,984
-1,194
| -38% | -$40 | 0.01% | 744 |
|
|
2022
Q3 | $153K | Hold |
3,178
| – | – | 0.01% | 687 |
|
|
2022
Q2 | $181K | Buy |
3,178
+1,985
| +166% | +$113K | 0.02% | 669 |
|
|
2022
Q1 | $96K | Buy |
+1,193
| New | +$96K | 0.01% | 728 |
|
|
2018
Q1 | – | Sell |
-677
| Closed | -$606K | – | 435 |
|
|
2017
Q4 | $606K | Hold |
677
| – | – | 0.13% | 192 |
|
|
2017
Q3 | $244K | Hold |
677
| – | – | 0.06% | 322 |
|
|
2017
Q2 | $198K | Hold |
677
| – | – | 0.05% | 353 |
|
|
2017
Q1 | $238K | Buy |
+677
| New | +$238K | 0.06% | 304 |
|